Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Post Market
Current status date:
2006-07-31
Original market date: See footnote 1
1998-05-21
Product name:
OXIZOLE
DIN:
02230452
Product Monograph/Veterinary Labelling:
Date:
2004-01-15
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
VALEO PHARMA INC
16667 Hymus Blvd.
Kirkland
Quebec
Canada
H9H 4R9
Class:
Human
Dosage form(s):
Cream
Route(s) of administration:
Topical
Number of active ingredient(s):
1
Schedule(s):
OTC
American Hospital Formulary Service (AHFS): See footnote 3
84:04.08.08
Anatomical Therapeutic Chemical (ATC): See footnote 4
D01AC11 OXICONAZOLE
Active ingredient group (AIG) number:See footnote5
0133080001
Active ingredient(s) See footnote8 | Strength |
---|---|
OXICONAZOLE (OXICONAZOLE NITRATE) | 1 % |